13F HOLDINGS REPORT
Foresite Capital Management V, LLC
Quarter ended Q2 2023 · Filed May 12, 2023 · Accession 0001104659-23-059499
Total Value
$135.3M
Positions
11
Other Managers
0
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Hims & Hers Health, Inc. | HIMS | 3,733,381 | $37.0M | 27.38% |
| 2 | Theseus Pharmaceuticals, Inc. | 88369M101 | 3,585,346 | $31.8M | 23.54% |
| 3 | Pardes Biosciences Inc | 69945Q105 | 10,037,935 | $13.3M | 9.79% |
| 4 | Kinnate Biopharma Inc. | 49705R105 | 1,975,001 | $12.3M | 9.12% |
| 5 | Compass Therapeutics, Inc. | CMPX | 3,480,723 | $11.4M | 8.41% |
| 6 | Aclaris Therapeutics, Inc. | ACRS | 1,258,243 | $10.2M | 7.52% |
| 7 | Somalogic, Inc. | 83444K105 | 3,516,472 | $9.0M | 6.63% |
| 8 | Disc Medicine, Inc. | IRON | 243,513 | $5.2M | 3.81% |
| 9 | Adicet Bio, Inc. | ACET | 558,636 | $3.2M | 2.38% |
| 10 | Quantum Si Inc | QSIAW | 924,404 | $1.6M | 1.20% |
| 11 | Pharvaris N.V. | PHVS | 34,142 | $275,014 | 0.20% |